Xenobiotica

Regional and cellular distribution of CYP2D subfamily members in rat brain
pp. 547-564(18)
Authors: Miksys S.; Rao Y.; Sellers E. M.; Kwan M.; Mendis D.; Tyndale R. F.

Identification of enzymes responsible for rifalazil metabolism in human liver microsomes
pp. 565-574(10)
Authors: Mae T.; Inaba T.; Konishi E.; Hosoe K.

Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences
pp. 575-588(14)
Authors: Kraus B.L.H.; Greenblatt D. J.; Venkatakrishnan K.; Court M. H.

Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up
pp. 589-607(19)
Authors: Meunier V.; Bourrie M.; Julian B.; Marti E.; Guillou F.; Berger Y.; Fabre G.

Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum
pp. 609-617(9)
Authors: De Santi C.; Pietrabissa A.; Spisni R.; Mosca F.; Pacifici G. M.

An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys
pp. 619-625(7)
Authors: Krausz K. W.; Goldfarb I.; Yang T. J.; Gonzalez F. J.; Gelboin H. V.

Pharmacokinetics and metabolism of a sulphamide NK₂ antagonist in rat, dog and human
pp. 627-642(16)
Authors: Beaumont K.; Harper A.; Smith D. A.; Abel S.

Metabolism of a novel hypnotic, N³-phenacyluridine, and hypnotic and sedative activities of its enantiomer metabolites in mouse
pp. 643-653(11)
Authors: Kimura T.; Miki M.; Watanabe K.; Kondo S.; Ho I. K.; Yamamoto I.